Glucose tolerance and secretion and clearance of insulin during long term felodipine treatment.
Katzman
P L
PL
Department of Endocrinology, Lund University Clinics, Malmö.
Hulthén
U L
UL
Hökfelt
B
B
D000328:Adult; D000959:Antihypertensive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002096:C-Peptide / Q000097:blood; D015736:Felodipine; D005934:Glucagon / Q000097:blood; D005951:Glucose Tolerance Test; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000188:drug therapy*; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D008297:Male; D008875:Middle Aged; D009568:Nitrendipine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000959:Antihypertensive Agents; D002096:C-Peptide; D007328:Insulin; D005934:Glucagon; D009568:Nitrendipine; D015736:Felodipine